IO Biotech, Inc. Quarterly Income Tax Expense (Benefit) in USD from Q1 2021 to Q3 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
IO Biotech, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2021 to Q3 2024.
- IO Biotech, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $209K.
- IO Biotech, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $1.35M, a 9.15% decline year-over-year.
- IO Biotech, Inc. annual Income Tax Expense (Benefit) for 2023 was $852K, a 33.1% decline from 2022.
- IO Biotech, Inc. annual Income Tax Expense (Benefit) for 2022 was $1.27M, a 1772% increase from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)